Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

Pfizer, First Solar, Six Flags, Equity Residential, Vertiv, Moderna, and Powell Industries. Donald Trump Suffers Major Blow ...

Pfizer is trying to increase doctor awareness of and testing for a rare lung cancer mutation to help boost use of its drug ...

A drug that could reduce the risk of death in cancer patients is showing good promise during its second phase of clinical ...

The results could pave the way for Pfizer's drug ponsegromab to become the first-ever approved treatment specifically for ...

Inspired by Pfizer’s response to the COVID pandemic, Miguel Agreda ’25 brought his skills as a joint-degree MBA/MPH student ...

There’s a new coronavirus subvariant catching the attention of global doctors and researchers: it’s being called “XEC.” ...

Pfizer PFE stock has risen 7.3% in the past three months compared with an increase of 2.9% for the industry. The stock has also outperformed the sector as well as the S&P 500, as seen in the chart ...

Acepodia, a start-up developing cell therapies, is collaborating with Pfizer Ignite, which will offer research and development support for drug candidates targeting autoimmune diseases. Acepodia is ...

Pharmaceutical giant Pfizer (NYSE: PFE) stands out in this context. The company currently offers a mouthwatering 5.7% ...

Providing a diverse range of perspectives from bullish to bearish, 13 analysts have published ratings on Pfizer PFE in the ...

An Illinois mistrial involving the recalled medication Zantac is the latest court decision involving the recalled drug, but ...